GENESCO INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.2 USD | +0.46% |
|
+2.30% | -25.59% |
| Mar. 08 | Genesco Shares Decline Following Q4 Earnings Report | MT |
| Mar. 08 | Transcript : Genesco Inc., Q4 2024 Earnings Call, Mar 08, 2024 |
Valuation
| Fiscal Period: February | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 593.9 | 621.4 | 907.5 | 623.7 | 331 | 300.7 | - | - |
| Enterprise Value (EV) 1 | 593.9 | 621.4 | 907.5 | 623.7 | 331 | 300.7 | 300.7 | 300.7 |
| P/E ratio | 10.3 x | -10.4 x | 7.84 x | - | - | - | - | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.27 x | 0.35 x | 0.37 x | 0.26 x | 0.14 x | 0.13 x | 0.13 x | 0.13 x |
| EV / Revenue | 0.27 x | 0.35 x | 0.37 x | 0.26 x | 0.14 x | 0.13 x | 0.13 x | 0.13 x |
| EV / EBITDA | 3.99 x | 18.2 x | 4.67 x | 4.47 x | - | 4.71 x | 3.73 x | - |
| EV / FCF | 6.79 x | 4.65 x | 4.41 x | -2.77 x | - | 15.7 x | 33.2 x | 20.3 x |
| FCF Yield | 14.7% | 21.5% | 22.7% | -36% | - | 6.38% | 3.02% | 4.92% |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 14,700 | 14,992 | 14,607 | 12,610 | 11,489 | 11,476 | - | - |
| Reference price 2 | 40.40 | 41.45 | 62.13 | 49.46 | 28.81 | 26.20 | 26.20 | 26.20 |
| Announcement Date | 3/12/20 | 3/11/21 | 3/10/22 | 3/9/23 | 3/8/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: February | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,197 | 1,787 | 2,422 | 2,385 | 2,325 | 2,234 | 2,258 | 2,388 |
| EBITDA 1 | 148.7 | 34.23 | 194.5 | 139.6 | - | 63.9 | 80.6 | - |
| EBIT 1 | 99.17 | -11.77 | 151.5 | 155.6 | 16.78 | 14.72 | 35.94 | 30.69 |
| Operating Margin | 4.51% | -0.66% | 6.26% | 6.52% | 0.72% | 0.66% | 1.59% | 1.29% |
| Earnings before Tax (EBT) | 82.44 | - | 153 | - | - | - | - | - |
| Net income | 61.76 | -56.43 | 114.8 | - | - | - | - | - |
| Net margin | 2.81% | -3.16% | 4.74% | - | - | - | - | - |
| EPS | 3.940 | -3.970 | 7.920 | - | - | - | - | - |
| Free Cash Flow 1 | 87.4 | 133.6 | 206 | -224.8 | - | 19.18 | 9.068 | 14.78 |
| FCF margin | 3.98% | 7.48% | 8.5% | -9.43% | - | 0.86% | 0.4% | 0.62% |
| FCF Conversion (EBITDA) | 58.76% | 390.36% | 105.89% | - | - | 30.02% | 11.25% | - |
| FCF Conversion (Net income) | 141.53% | - | 179.34% | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/12/20 | 3/11/21 | 3/10/22 | 3/9/23 | 3/8/24 | - | - | - |
1USD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: February | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 600.5 | 727.7 | 520.7 | 535.3 | 603.8 | 725 | 483.3 | 523 | 579.3 | 739 | 444.4 | 493.3 | 570.2 | 725.9 | 440.5 |
| EBITDA 1 | 55.23 | 77.37 | - | - | - | - | - | - | - | - | -26 | -10 | 25 | 73 | -20 |
| EBIT 1 | 45.23 | 66.37 | 9.489 | 9.973 | 26.33 | 83.38 | -22.69 | -10 | 10.95 | 38.52 | -37.9 | -14.42 | 15.1 | 51.94 | -20 |
| Operating Margin | 7.53% | 9.12% | 1.82% | 1.86% | 4.36% | 11.5% | -4.69% | -1.91% | 1.89% | 5.21% | -8.53% | -2.92% | 2.65% | 7.16% | -4.54% |
| Earnings before Tax (EBT) | 43.12 | 82.81 | 7.851 | 8.627 | 25.12 | 48.48 | - | - | - | - | - | - | - | - | - |
| Net income | 32.9 | 62.14 | 4.947 | 7.643 | 20.38 | 38.95 | - | - | - | - | - | - | - | - | - |
| Net margin | 5.48% | 8.54% | 0.95% | 1.43% | 3.37% | 5.37% | - | - | - | - | - | - | - | - | - |
| EPS | 2.250 | 4.410 | 0.3700 | 0.5900 | 1.650 | 3.230 | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 12/3/21 | 3/10/22 | 5/26/22 | 9/1/22 | 12/2/22 | 3/9/23 | 5/25/23 | 8/31/23 | 12/1/23 | 3/8/24 | - | - | - | - | - |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: February | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 87.4 | 134 | 206 | -225 | - | 19.2 | 9.07 | 14.8 |
| ROE (net income / shareholders' equity) | 10.6% | -2.82% | 18.9% | 11.8% | - | 1.2% | 2.3% | 3.3% |
| ROA (Net income/ Total Assets) | 5.02% | -1.02% | 7.02% | 4.71% | - | 0.5% | 1% | 1.5% |
| Assets | 1,231 | 5,511 | 1,636 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share 2 | - | 11.10 | 16.50 | -13.00 | - | 6.490 | 5.720 | 6.380 |
| Capex 1 | 29.8 | 24.1 | 54 | 50 | 149 | 54.1 | 55.5 | 57.3 |
| Capex / Sales | 1.35% | 1.35% | 2.23% | 2.1% | 6.41% | 2.42% | 2.46% | 2.4% |
| Announcement Date | 3/12/20 | 3/11/21 | 3/10/22 | 3/9/23 | 3/8/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
26.2
USD
Average target price
28
USD
Spread / Average Target
+6.87%
| 1st Jan change | Capi. | |
|---|---|---|
| -25.59% | 301M | |
| +14.99% | 151B | |
| +18.29% | 80.65B | |
| -3.45% | 44.8B | |
| -15.30% | 44.23B | |
| +1.89% | 26.43B | |
| +12.34% | 13.71B | |
| -5.29% | 11.76B | |
| +8.80% | 9.19B | |
| +2.10% | 7.97B |
- Stock Market
- Equities
- GCO Stock
- Financials Genesco Inc.
